INTRODUCTION
============

The term endometriosis refers to the presence of endometrial tissue outside the uterine cavity.^[@r01]-[@r10]^ It is considered a common disease prevalent in approximately 12% of women of reproductive age. Its etiopathogeny, however, is not yet well established. The most accepted theory is that of \"implantation\", described in 1927 by Sampson, which is based on the retrograde menstrual flow where endometrial tissue implants would travel during menstruation and settle in other places such as the ovary and peritoneum. However, it is known that up to 90% of women have this type of bleeding and only a minority will develop the disease.^[@r08]^ Another form derived from this same theory, would be the iatrogenic implantation during surgical procedures such as a cesarean section, where the growth of this tissue would normally be found on the surgical scar.

Umbilical endometriosis is rare, representing 0.5% to 1% of all endometriosis cases. Antonio Carlos Pereira Junior et al was the first Brazilian to describe the disease, in these annals, in 1970. This kind of endometriosis can be classified as primary, when it comes**\"de novo\"** or secondary, when it comes after surgical procedures. The umbilicus, considered a physiologic scar, could have tropism for endometrial cells, as seen in other scar tissues.^[@r08]^

The designation secondary endometriosis can be used even when it is not located on surgical scars, such as on the umbilicus, but only if its onset occurs within 2 years after the procedure.^[@r08],[@r09]^ Clinically it presents as a reddish-brown nodule, commonly painful, with cyclic variations in size, with or without bleeding, that may coincide or not with the patient\'s menstrual cycle.^[@r04]^

As for the differential diagnosis, mainly melanoma, umbilical metastasis (Mary Sister Joseph nodule), keloid and pyogenic granuloma should be considered.^[@r01]-[@r10]^ The histopathology is also changeable depending on the endometrial phase biopsied. The general feature is the absence of or discrete epidermal findings; in the dermis, fibroblast proliferation, seen as spindle cells.^[@r01]-[@r07],[@r09]^ The endometrial tissue, better seen when stained by anti CD10, is present in the dermis and can demonstrate the proliferative phase, when it will be possible to identify endometrial glands with intense mitotic activity or the secretory phase, in which glands with decapitation secretion will be present.^[@r09]^ Findings of hemosiderin in the dermis may be present, representing prior bleeding, better evidenced when stained by Pearls.^[@r05]^

A screening for pelvic endometriosis is mandatory. An elevated Ca-125 (cancer antigen 125) dosage can alert to this concomitance. This antigen is best known as a blood marker for ovarian cancer but it may also be elevated in other cancers and benign conditions, such as endometriosis. Images, initially with USG and later with NMR (nuclear magnetic resonance) can detect that presence more accurately. However, video laparoscopy is still the \"golden key\" to diagnose pelvic endometriosis.^[@r10]^

Dermoscopy is found to assist in the diagnosis of this rare entity. In the literature, there was only one case reported by Di Giorgi et al in 2003, where the author proposes dermoscopic findings in the diagnosis of a presented case. It describes homogeneous red coloration, regularly distributed, fading to the periphery. Within this usual pigmentation some small red globular structures are described, that he refers to as \"red atolls\". After a dermoscopic-histopathologic correlation the authors show that these \"red atolls\" would correspond to irregular glands containing erythrocytes embedded in a cellular stroma and the red homogeneous aspect would correspond to vascular stroma with myxoid appearance containing extravasated erythrocytes.^[@r03],[@r07]^

The first line treatment is surgical, due to high incidence of recurrence and also the possibility of malignant transformation. Pretreatment with hormones is also an option especially in larger tumors, providing a reduction in size before surgery.^[@r09],[@r10]^

CASE REPORT
===========

Female, 32 years old, came to our service complaining about a 3-month growth in the umbilical area. The lesion was a shiny reddish-brown nodule, measuring 3cmx3cm, painful to the touch and that alternated in size since its onset ([Figure 1](#f01){ref-type="fig"}). The patient referred one episode of spontaneous bleeding that did not follow her menstrual cycle. She had had a cesarean delivery 6 years ago and no gynecologic complaints. After clinical examination, dermoscopic observation was performed, using a polarized light dermatoscope (DermLite II Pro HR). It showed homogeneous reddish localized pigmentation, with no differentiated structures. In addition, an amorphous brown area was present, where normal skin network was more evident in some parts ([Figure 2](#f02){ref-type="fig"}). The biopsy revealed fibroblastic proliferation in the dermis and endometrial glandular tissue, of the decapitation secretion type ([Figures 3](#f03){ref-type="fig"} and [4](#f04){ref-type="fig"}). It also revealed deposit of hemosiderin in the dermis as an evidence of previous bleeding ([Figure 5](#f05){ref-type="fig"}). The diagnosis of primary umbilical endometriosis was established. All the imaging exams as well as the Ca-125 dosage were normal.

![Umbilical endometriosis. Clinical aspect. A shiny reddish-brown tumor, with well defined limits, located on the umbilicus scar. The patient referred one episode of spontaneous bleeding](abd-88-0121-g01){#f01}

![Umbilical endometriosis. Dermoscopic aspect by epiluminescence microscopy. 10x magnification. Number 1: a regular pigmented network is noticed in its central area. Number 2: an amorphous brown area with white scar tissue in the center, caused by a biopsy procedure. Number 3: a homogeneous reddish pigmentation is regularly distributed](abd-88-0121-g02){#f02}

![Umbilical endometriosis. Histopathological aspect. Stained by Hematoxylin and Eosin (HE). On left lower portion, epidermis with discrete acanthosis. In the dermis, a myxoid stroma aspect with fibroblastic proliferation, evidenced by the spinde-shaped cells. On the upper right portion, glandular type cells, characteristic of endometriosis](abd-88-0121-g03){#f03}

![Umbilical endometriosis. Histopathological aspect, stained by Hematoxylin and Eosin (HE). The upper right portion of the first histopathological picture shows a higher approach to the decapitation secretion of the glandular cells. These features belong to the secretory phase of the glandular epithelium](abd-88-0121-g04){#f04}

![Umbilical Endometriosis. Histopathological aspect. Stained by Hematoxylin and Eosin (HE). In the dermis, hemosiderin deposit located mostly around vessels is evidence of previous bleeding](abd-88-0121-g05){#f05}

DISCUSSION
==========

Cutaneous umbilical endometriosis is a rare entity, representing 0.5% to 1% of all endometriosis cases. As described before, its primary form can arise spontaneously with or without associated symptoms, such as in the presented case where the absence of symptoms made the diagnosis more difficult. The presence of spontaneous bleeding, as well as the color of the lesion should alert the clinician to the possibility of melanoma diagnosis.

A biopsy is mandatory in all cases, especially when melanoma cannot be ruled out. Therefore, we suggest dermoscopy as an auxiliary tool in the physical examination of these patients.

Our dermoscopic findings were only in part similar to the previous reported cases. The presence of the reddish homogeneous pigmentation was observed only in one part of the lesion and there was no evidence of the \"red atolls\" described before. We considered that such differences could come from the different phases when the evaluation was performed. Our hypothesis, however, can only be proven with other evaluations in different phases of endometriosis. Therefore, this case report has as the objective of providing contributions to describe and clearly establish the dermoscopic features of cutaneous endometriosis.
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